keyword
https://read.qxmd.com/read/38612981/identification-of-new-allergens-in-macadamia-nut-and-cross-reactivity-with-other-tree-nuts-in-a-spanish-cohort
#21
JOURNAL ARTICLE
Gloria Gutiérrez-Díaz, Diana Betancor, Jorge Parrón-Ballesteros, Rubén G Gordo, Estela S Castromil-Benito, Elisa Haroun, María Vázquez de la Torre, Javier Turnay, Mayte Villalba, Javier Cuesta-Herranz, Carlos Pastor-Vargas
The consumption of macadamia nuts has increased due to their cardioprotective and antioxidant properties. However, this rise is consistent with an increase in the cases of macadamia nut allergy, leading to severe reactions. Although two Macadamia integrifolia allergens (Mac i 1 and Mac i 2) have been identified in Australian and Japanese patients, the allergenic sensitization patterns in Western European populations, particularly in Spain, remain unclear. For this purpose, seven patients with macadamia nut allergy were recruited in Spain...
March 26, 2024: Nutrients
https://read.qxmd.com/read/38612386/detection-of-sensitization-profiles-with-cellular-in-vitro-tests-in-wheat-allergy-dependent-on-augmentation-factors-walda
#22
JOURNAL ARTICLE
Valentina Faihs, Viktoria Schmalhofer, Claudia Kugler, Rebekka K Bent, Katharina A Scherf, Barbara Lexhaller, Charlotte G Mortz, Carsten Bindslev-Jensen, Tilo Biedermann, Per S Skov, Bernadette Eberlein, Knut Brockow
Wheat allergy dependent on augmentation factors (WALDA) is the most common gluten allergy in adults. IgE-mediated sensitizations are directed towards ω5-gliadin but also to other wheat allergens. The value of the different in vitro cellular tests, namely the basophil activation test (BAT) and the active (aBHRA) and passive basophil histamine-release assays (pBHRA), in the detection of sensitization profiles beyond ω5-gliadin has not been compared. Therefore, 13 patients with challenge-confirmed, ω5-gliadin-positive WALDA and 11 healthy controls were enrolled...
March 22, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611357/spirulina-arthrospira-platensis-antiallergic-agent-or-hidden-allergen-a-literature-review
#23
REVIEW
Weronika Gromek, Natalia Kołdej, Marcin Kurowski, Emilia Majsiak
Presently, there has been an increase in the consumption of the blue-green microalga-spirulina ( Arthrospira species), which dominates 99.5% of the total world production of microalgae. Primarily sold as a dietary supplement, it is also incorporated into snacks, pasta, cookies, and bread. Owing to its nutrient abundance, spirulina has a variety of potential applications. Extensive studies have been conducted on the health benefits of spirulina, but its safety in terms of allergy has received limited attention...
March 29, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38611300/the-magnitude-and-impact-of-food-allergens-and-the-potential-of-ai-based-non-destructive-testing-methods-in-their-detection-and-quantification
#24
REVIEW
Akinbode A Adedeji, Paul V Priyesh, Adeniyi A Odugbemi
Reaction to food allergens is on the increase and so is the attending cost on consumers, the food industry, and society at large. According to FDA, the "big-eight" allergens found in foods include wheat (gluten), peanuts, egg, shellfish, milk, tree nuts, fish, and soybeans. Sesame was added to the list in 2023, making the target allergen list nine instead of eight. These allergenic foods are major ingredients in many food products that can cause severe reactions in those allergic to them if found at a dose that can elicit a reaction...
March 25, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38606487/covid-19-and-asthma-onset-in-children
#25
JOURNAL ARTICLE
James P Senter, Laura K Aisenberg, Jesse W Dudley, Xianqun Luan, Jing Huang, Chén C Kenyon, David A Hill
BACKGROUND AND OBJECTIVES: Respiratory viral infections increase risk of asthma in infants and children. Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus can cause severe lung inflammation and prolonged respiratory symptoms. We sought to determine whether SARS-CoV-2 infection modified pediatric incident asthma risk. METHODS: This retrospective cohort study examined children ages 1 to 16 within the Children's Hospital of Philadelphia Care Network who received polymerase chain reaction (PCR) testing for SARS-CoV-2 between March 1, 2020 and February 28, 2021...
April 12, 2024: Pediatrics
https://read.qxmd.com/read/38602246/assessing-and-comparing-potential-allergenicity-of-two-partially-hydrolyzed-whey-based-formulas-for-infants-a-population-based-study-in-china
#26
JOURNAL ARTICLE
Lijuan Sun, Shiwen Han, Sufang Duan, Like Mao, Fang Li, Zhenhua Tu, Huilian Che
SCOPE: In cases where breast milk is unavailable or inadequate, hydrolyzed infant formula is recommended as the primary alternative. The aim of this study is to assess and compare the allergenicity of two partially hydrolyzed whey-based formulas (PHF-Ws) using serum samples from patients with cow's milk allergy (CMA). METHODS AND RESULTS: LC-MS/MS technology is used to investigate the peptide distribution in both samples. The immunoreactivity of two PHF-Ws in 27 serum samples from 50 Chinese infants (02 years) with CMA is analyzed...
April 11, 2024: Molecular Nutrition & Food Research
https://read.qxmd.com/read/38601963/effects-of-flavourzyme-and-alkaline-protease-treatment-on-structure-and-allergenicity-of-peanut-allergen-ara-h-1
#27
JOURNAL ARTICLE
Erlian Shu, Shuo Wang, Xiangxiang Kong, Xiaodong Sun, Qiaoling Yang, Qin Chen, Bing Niu
RESEARCH BACKGROUND: Peanut allergy poses a significant threat to human health due to the increased risk of long-term morbidity at low doses. Modifying protein structure to affect sensitization is a popular topic. EXPERIMENTAL APPROACH: In this study, the purified peanut allergen Ara h 1 was enzymatically hydrolysed using Flavourzyme, alkaline protease or a combination of both. The binding ability of Ara h 1 to antibodies, gene expression and secretion levels of the proinflammatory factors interleukin-5 and interleukin-6 in Caco-2 cells was measured...
March 2024: Food Technology and Biotechnology
https://read.qxmd.com/read/38601864/safety-evaluation-of-the-food-enzyme-amp-deaminase-from-non-genetically-modified-aspergillus-sp-strain-dea-56-111
#28
JOURNAL ARTICLE
Claude Lambré, José Manuel Barat Baviera, Claudia Bolognesi, Pier Sandro Cocconcelli, Riccardo Crebelli, David Michael Gott, Konrad Grob, Evgenia Lampi, Marcel Mengelers, Alicja Mortensen, Gilles Rivière, Inger-Lise Steffensen, Christina Tlustos, Henk Van Loveren, Laurence Vernis, Holger Zorn, Lieve Herman, Yrjö Roos, Magdalena Andryszkiewicz, Daniele Cavanna, Natália Kovalkovičová, Yi Liu, Simone Lunardi, Andrew Chesson
The food enzyme AMP deaminase (AMP aminohydrolase; EC 3.5.4.6) is produced with the non-genetically modified microorganism Aspergillus sp. strain DEA 56-111 by Shin Nihon Chemical Co., Ltd. The food enzyme was considered free from viable cells of the production organism. It is intended to be used in the processing of yeast and yeast products. Dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be up to 0.005 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern...
April 2024: EFSA journal
https://read.qxmd.com/read/38601382/no-association-between-allergic-diseases-and-constipation-in-japanese-ulcerative-colitis-patients-a-cross-sectional-study
#29
JOURNAL ARTICLE
Sen Yagi, Shinya Furukawa, Seiyuu Suzuki, Katsuhisa Ohashi, Hideomi Tomida, Yasunori Yamamoto, Eiji Takeshita, Yoshio Ikeda, Yoichi Hiasa
BACKGROUND: Constipation is a common gastrointestinal symptom in patients with ulcerative colitis (UC). Several studies on the general population have demonstrated a link between allergic diseases and constipation. However, evidence regarding the association between allergic diseases and constipation in UC is limited. This study aims to evaluate this issue in Japanese patients with UC. METHODS: This cross-sectional study recruited consecutive 387 patients with UC...
March 2024: Curēus
https://read.qxmd.com/read/38600019/gut-microbiota-of-one-and-a-half-year-old-food-allergic-and-healthy-children
#30
JOURNAL ARTICLE
Monami Hara, Hisato Suzuki, Daisuke Hayashi, Wataru Morii, Takako Nakamura, Kaori Kiyoki, Hideki Hara, Ryota Ishii, Emiko Noguchi, Hidetoshi Takada
BACKGROUND: Intestinal bacteria may play a role in the development of food allergies. This study aimed to analyze and compare the gut microbiota of food-allergic children with that of healthy children of the same age. METHODS: Stool samples were collected from one-and-a-half-year-old food-allergic (FA group, n = 29) and healthy controls (HC group, n = 19). A questionnaire was provided to examine the children's birth, dietary, medical, and social histories...
April 9, 2024: Allergology International: Official Journal of the Japanese Society of Allergology
https://read.qxmd.com/read/38599291/a-practical-guide-for-implementing-omalizumab-therapy-for-food-allergy
#31
REVIEW
Thomas B Casale, Alessandro Fiocchi, Matthew Greenhawt
The recent approval of omalizumab for the treatment of IgE-mediated food allergy is an important step forward for the millions of food allergy patients in the US. Through the depletion of circulating IgE and the subsequent reduction of FCεR1 on key effector cells, patients increase their tolerance to food allergens. However, omalizumab does not permit patients to eat foods that they are allergic to with impunity. Rather, it protects them from most accidental exposures. In addition, omalizumab does not cure food allergy and has not demonstrated true immunomodulation...
April 8, 2024: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/38597862/preparing-patients-for-oral-immunotherapy-ppoint-international-delphi-consensus-for-procedural-preparation-and-consent
#32
JOURNAL ARTICLE
Douglas P Mack, Timothy E Dribin, Paul J Turner, Richard L Wasserman, Mariam A Hanna, Marcus Shaker, Mimi L K Tang, Pablo Rodríguez Del Río, Brad Sobolewski, Elissa M Abrams, Aikaterini Anagnostou, Stefania Arasi, Sakina Bajowala, Philippe Bégin, Scott B Cameron, Edmond S Chan, Sharon Chinthrajah, Andrew T Clark, Paul Detjen, George du Toit, Motohiro Ebisawa, Arnon Elizur, Jeffrey M Factor, Justin Greiwe, Jonathan O'B Hourihane, Sarah W Hughes, Douglas H Jones, Antonella Muraro, Anna Nowak-Wegrzyn, Nandinee B Patel, Amy M Scurlock, Atul N Shah, Sayantani B Sindher, Stephen Tilles, Brian P Vickery, Julie Wang, Hugh H Windom, Matthew Greenhawt
BACKGROUND: Despite the promise of oral immunotherapy (OIT) to treat food allergies, this procedure is associated with potential risk. There is no current agreement about what elements should be included in the preparatory or consent process. OBJECTIVE: We developed consensus recommendations about the OIT process considerations and patient-specific factors that should be addressed before initiating OIT and developed a consensus OIT consent process and information form...
March 28, 2024: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/38597846/the-prevalence-of-ige-mediated-food-allergy-and-other-allergic-diseases-in-the-first-10-years-the-population-based-longitudinal-healthnuts-study
#33
JOURNAL ARTICLE
Rachel L Peters, Victoria X Soriano, Katrina J Allen, Mimi L K Tang, Kirsten P Perrett, Adrian J Lowe, Rushani Wijesuriya, Kayla M Parker, Paxton Loke, Shyamali C Dharmage, Jennifer J Koplin
BACKGROUND: There are limited longitudinal data on the population prevalence of allergic conditions during childhood, and few studies have incorporated the reference standard oral food challenge to confirm food allergy. OBJECTIVE: To describe the population prevalence of IgE-mediated food allergy, eczema, asthma, and rhinitis at ages 6 and 10 years in Melbourne, Australia. METHODS: The HealthNuts study recruited 5,276 1-year-old infants in Melbourne, Australia, with repeat assessments at ages 6 and 10 years...
April 8, 2024: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/38596434/evolving-strategies-enhancements-in-managing-eosinophilic-esophagitis-in-pediatric-patients
#34
REVIEW
Ahmed Elghoudi, Doaa Zourob, Eman Al Atrash, Fatima Alshamsi, Manal Alkatheeri, Hassib Narchi, Rana Bitar
Eosinophilic esophagitis is a newly recognized disease first described about 50 years ago. The definition, diagnosis, and management have evolved with new published consensus guidelines and newly approved treatment available to pediatricians, enabling a better understanding of this disease and more targeted treatment for patients. We describe the definition, presentation, and diagnosis of eosinophilic esophagitis including management, challenges, and future directions in children. The definition, diagnosis, and management of eosinophilic esophagitis have evolved over the last 50 years...
March 9, 2024: World Journal of Clinical Pediatrics
https://read.qxmd.com/read/38595790/food-allergy-issues-among-consumers-a-comprehensive-review
#35
REVIEW
Samantha Sansweet, Ria Jindal, Ruchi Gupta
Food Allergy (FA) is a growing global public health concern. In the United States alone, 8% of children and 11% of adults have a convincing FA (symptoms consistent with an IgE-mediated reaction to a specific allergen). Given the significant prevalence of this condition, the objective of this mini-review is to illustrate the many dimensions of life that are impacted among those with FA. Summarizing findings from a breadth of current literature, we present how FA affects social, psychological, and economic-related quality of life...
2024: Frontiers in Nutrition
https://read.qxmd.com/read/38595024/aluminium-in-dermatology-inside-story-of-an-innocuous-metal
#36
REVIEW
Aravind Baskar Murthy, Vijayasankar Palaniappan, Kaliaperumal Karthikeyan
Aluminium, the third most abundant element in the earth's crust, was long considered virtually innocuous to humans but has gained importance in the recent past. Aluminium is ubiquitous in the environment, with various sources of exposure like cosmetics, the food industry, occupational industries, the medical field, transport and electronics. Aluminium finds its utility in various aspects of dermatology as an effective haemostatic agent, anti-perspirant and astringent. Aluminium has a pivotal role to play in wound healing, calciphylaxis, photodynamic therapy and vaccine immunotherapy with diagnostic importance in Finn chamber patch testing and confocal microscopy...
February 9, 2024: Indian Journal of Dermatology, Venereology and Leprology
https://read.qxmd.com/read/38593870/targeting-inhibitory-siglec-3-to-suppress-ige-mediated-human-basophil-degranulation
#37
JOURNAL ARTICLE
Suzanne M Barshow, Maidul Islam, Scott Commins, Matthew S Macauley, James C Paulson, Michael D Kulis
BACKGROUND: Siglec-3 (CD33) is a major Siglec expressed on human mast cells and basophils and engagement of CD33 leads to inhibition of cellular signaling via immunoreceptor tyrosine-based inhibitory motifs (ITIMs). OBJECTIVE: We sought to inhibit human basophil degranulation by simultaneously recruiting inhibitory CD33 to the IgE-FcεRI complex using monoclonal anti-IgE directly conjugated to CD33 ligand (CD33L). METHODS: Direct and indirect basophil activation tests (BAT) were used to assess both antigen-specific (peanut) and antigen non-specific (polyclonal anti-IgE) stimulation...
April 7, 2024: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/38591129/basophil-activation-test-in-the-food-allergy-clinic-its-current-use-and-future-applications
#38
REVIEW
Marcel M Bergmann, Alexandra F Santos
INTRODUCTION: The basophil activation test (BAT) has shown evidence of high sensitivity and high specificity to support the diagnosis of IgE-mediated allergy. It is a functional test that uses live cells analyzed by flow cytometry and thus needs to be performed within 24h of blood collection. BAT has shown to be reproducible and reliable when tested in a clinical diagnostic laboratory with standardized protocols and flow cytometry settings. AREAS COVERED: In this review, we summarize the evidence to support clinical use of BAT and the next steps required for clinical implementation for an improve clinical care for patients with suspected IgE-mediated food allergy...
April 10, 2024: Expert Review of Clinical Immunology
https://read.qxmd.com/read/38591025/safety-evaluation-of-the-food-enzyme-bacillolysin-from-the-non-genetically-modified-bacillus-amyloliquefaciens-strain-ae-np
#39
JOURNAL ARTICLE
Claude Lambré, José Manuel Barat Baviera, Claudia Bolognesi, Pier Sandro Cocconcelli, Riccardo Crebelli, David Michael Gott, Konrad Grob, Evgenia Lampi, Marcel Mengelers, Alicja Mortensen, Gilles Rivière, Inger-Lise Steffensen, Christina Tlustos, Henk Van Loveren, Laurence Vernis, Holger Zorn, Yrjö Roos, Magdalena Andryszkiewicz, Daniele Cavanna, Simone Lunardi, Francesco Pesce, Andrew Chesson
The food enzyme bacillolysin (EC 3.4.24.28) is produced with the non-genetically modified Bacillus amyloliquefaciens strain AE-NP by Amano Enzyme Inc. The production strain meets the requirements for the qualified presumption of safety (QPS) approach to safety assessment. The food enzyme is intended to be used in 14 food manufacturing processes. Since residual amounts of total organic solids (TOS) are removed in three manufacturing processes, dietary exposure was calculated only for the remaining 11 food manufacturing processes in which the food enzyme-TOS is retained...
April 2024: EFSA journal
https://read.qxmd.com/read/38587178/discontinuing-semaglutide-after-weight-loss-strategy-for-weight-maintenance-and-a-possible-new-side-effect
#40
JOURNAL ARTICLE
Nicholas W Carris, Shawn Wallace, Christopher G DuCoin, Rahul Mhaskar, Marilyn Stern, Brian Bunnell
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) facilitate weight loss. Weight regain off therapy is concerning. We reported the case of a 35-year-old male prescribed oral semaglutide with 22.7 kg weight loss over 120 days. Herein, we describe the clinical course when discontinuing GLP-1 RA therapy, one approach to maintaining weight loss after discontinuation, and a possible new side effect. At day 120, we continued oral semaglutide 7 mg daily, down from 14 mg, for weight maintenance with subsequent weight regain...
April 8, 2024: Canadian Journal of Physiology and Pharmacology
keyword
keyword
60003
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.